Our recent study has revealed a novel tumor suppressive role for the glycolytic enzyme Aldob in HCC through directly binding to G6PD and inhibiting its activity, acting as a metabolic switch in glucose metabolism and regulating the metabolic reprogramming [18]. Here, G6PD is linked to hepatocellular carcinoma.